Nascent Biotech Inc. Annual Return On Assets in % from 2016 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Nascent Biotech Inc. quarterly/annual Return On Assets history and growth rate from 2016 to 2023.
  • Nascent Biotech Inc. Return On Assets for the quarter ending June 30, 2024 was -313 %, a 19.6% increase year-over-year.
  • Nascent Biotech Inc. annual Return On Assets for 2023 was -379 %, a 58.1% increase from 2022.
  • Nascent Biotech Inc. annual Return On Assets for 2022 was -905 %, a 344% decline from 2021.
  • Nascent Biotech Inc. annual Return On Assets for 2021 was -204 %, a 99.2% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -379 +526 +58.1% Apr 1, 2023 Mar 31, 2024
2022 -905 -701 -344% Apr 1, 2022 Mar 31, 2023
2021 -204 +23.9K +99.2% Apr 1, 2021 Mar 31, 2022
2020 -24.1K -20.1K -494% Apr 1, 2020 Mar 31, 2021
2019 -4.06K -3.89K -2232% Apr 1, 2019 Mar 31, 2020
2018 -174 +46.6 +21.1% Apr 1, 2018 Mar 31, 2019
2017 -221 -333 -297% Apr 1, 2017 Mar 31, 2018
2016 112 Apr 1, 2016 Mar 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.